Stereotaxis appoints new CMO

Image-guided interventional surgery firm Stereotaxis of St. Louis has appointed a new chief medical officer (CMO), the company said.

Dr. David Burkhardt, a former electrophysiologist at the Cleveland Clinic in Ohio, brings experience in the use of interventional magnetic navigation systems for the treatment of cardiovascular disease.

Burkhardt most recently served as associate program director for the Clinical Cardiac Electrophysiology Fellowship training program. His specialties include remote navigation, new technology assessment, and optimization of cardiac resynchronization therapy.

Related Reading

Stereotaxis reports continued growth for Q3, November 8, 2007

Stereotaxis growth in Q2 sales, net loss, August 10, 2007

Stereotaxis gets FDA OK for ablation catheter, April 3, 2007

Stereotaxis hits procedure milestone, January 25, 2007

Stereotaxis shows Q3 revenue gain, November 10, 2006

Copyright © 2008 AuntMinnie.com

Page 1 of 57
Next Page